New Genetics Based Melanoma Therapy
Posted by Pharmacist on August 30, 2011
Zelboraf Approved for Late-State Melanoma Patients with Mutation V600E According to Roche Diagnostics, nearly half of all patients with late-stage melanoma have a mutation in BRAF. The American Society of Health-System Pharmacists notes on its website that U.K. researchers found 80% of the BRAF mutations in malignant melanomas were caused by Mutation V600E. This is [...]



